Is GLP-1 Right for You? Key Questions to Ask Your Doctor

Considering GLP-1 medication for weight loss? Here are the essential questions to discuss with your healthcare provider to determine if it's the right fit.

Majesta Health Medical TeamMedically Reviewed
Reviewed Apr 12, 20267 min read

GLP-1 receptor agonists have become one of the most talked-about treatments in weight management. But like any medical intervention, they're not for everyone. Before starting treatment, it's important to have an honest conversation with your healthcare provider about whether GLP-1 medication is appropriate for your specific situation.

Here are the key questions to ask, and what you should know before your consultation.

Am I a Candidate for GLP-1 Treatment?

GLP-1 medications are generally prescribed for adults who meet certain clinical criteria. While every provider may have slightly different guidelines, the standard benchmarks include:

  • BMI of 30 or higher (classified as obesity)
  • BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea
  • Previous attempts at weight loss through diet and exercise that haven't achieved lasting results
  • It's worth noting that BMI is just one screening tool, your doctor will also consider your overall health history, family history, and individual risk factors.

    ### Why BMI Matters (and Its Limitations)

    BMI provides a quick snapshot of whether your weight falls within a range that may benefit from medical intervention. However, it doesn't account for muscle mass, bone density, or body composition. That's why a comprehensive medical evaluation is essential, not just a number on a chart.

    What Are the Potential Contraindications?

    Not everyone can safely take GLP-1 medications. Be sure to discuss the following with your doctor:

  • Personal or family history of medullary thyroid carcinoma (MTC): GLP-1 receptor agonists carry a boxed warning related to thyroid C-cell tumors observed in animal studies. If you or a close family member has had MTC, these medications are generally not recommended.
  • History of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): This genetic condition is a contraindication for GLP-1 use.
  • Pancreatitis: If you have a history of pancreatitis, your doctor will need to weigh the risks carefully.
  • Gallbladder disease: GLP-1 medications may increase the risk of gallbladder-related issues in some patients.
  • Severe gastrointestinal conditions: Conditions like gastroparesis (delayed stomach emptying) may be worsened by GLP-1 medications.
  • Pregnancy or breastfeeding: GLP-1 medications are not recommended during pregnancy or while breastfeeding.
  • What Should I Expect in Terms of Results?

    This is one of the most important questions, and one where realistic expectations matter.

    Clinical trials have shown that patients using semaglutide (the active ingredient in medications like Wegovy and compounded formulations) experience an average weight reduction of 15–20% of their body weight over 12 to 16 months.

    However, individual results vary significantly. Factors that influence your outcome include:

  • Your starting weight and metabolic profile
  • How consistently you take the medication
  • Your dietary habits and physical activity level
  • Genetic factors that influence how your body responds to the medication
  • Whether you're also managing other health conditions
  • The key takeaway: GLP-1 medication is not a magic pill. It's a powerful tool that works best when combined with sustainable lifestyle changes.

    What Questions Should I Bring to My Doctor?

    Here's a checklist of questions to discuss during your consultation:

    1. "Based on my health history, am I a good candidate for GLP-1 treatment?". Let your doctor evaluate your complete picture, not just your BMI.

    2. "Are there any drug interactions I should be aware of?". If you're taking other medications (especially insulin, sulfonylureas, or blood thinners), your doctor needs to check for interactions.

    3. "What's the typical dose escalation schedule?". GLP-1 medications are started at a low dose and gradually increased. Understanding the timeline helps set expectations.

    4. "What side effects should I watch for?". Common side effects include nausea, constipation, and decreased appetite. Most are mild and temporary, but knowing what to expect reduces anxiety.

    5. "How will my progress be monitored?". A good provider will schedule regular check-ins to track your weight, metabolic markers, and overall well-being.

    6. "What happens if I stop taking the medication?". Research suggests that weight regain is possible after discontinuation. Discuss long-term planning with your provider.

    7. "Is compounded semaglutide an option for me?". If cost is a barrier, ask about FDA-regulated compounded formulations that may be significantly more affordable.

    Who Should NOT Start GLP-1 Without Medical Supervision?

    To be clear: GLP-1 medications should always be prescribed and monitored by a licensed healthcare provider. However, certain groups need especially careful evaluation:

  • Patients with a history of eating disorders
  • Patients with severe kidney or liver disease
  • Patients over 65, who may need adjusted dosing
  • Patients with a history of suicidal ideation (some medications in this class have been studied for mental health effects)
  • How Majesta Health Can Help

    At Majesta Health, every patient consultation is conducted by a board-certified physician who evaluates your complete health profile. We don't use AI chatbots or automated prescribing, a real doctor reviews your case and makes a clinical determination.

    If GLP-1 treatment is appropriate for you, we create a personalized plan that includes medication, dose management, and ongoing support. If it's not appropriate, we'll tell you honestly and suggest alternatives.

    *Your health comes first. Always.*


    This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any medication. Individual results may vary.

    <!-- related-2026-injected -->

    Related 2026 guides

  • Online GLP-1 prescription in 2026: the honest guide
  • Compounded vs brand-name GLP-1 medications: the honest 2026 guide
  • Every GLP-1 brand and generic available in 2026
  • Medically reviewed

    Majesta Health Medical Team

    Clinical Editorial Team

    All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.

    Credentials and accreditation
    • US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
    • Board-certified in primary care and obesity medicine
    • Active state medical licensure required for every prescribing clinician
    • Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
    • Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
    • Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)
    Areas of expertise
    GLP-1 receptor agonist therapy (semaglutide, tirzepatide, liraglutide)Chronic weight managementObesity medicineCompounded medication clinical oversightTelehealth informed consent and patient screening
    Have a question for our medical team? See our full clinical team page or contact support.

    Ready to Reserve Your Spot?

    Join the founding-member waitlist for priority access and locked-in pricing.

    Start Your Assessment